title: Annexin II enhances cytomegalovirus binding and fusion to phospholipid membranes.
abstract: A number of studies have suggested that the anionic phospholipid (anPL)-binding protein annexin II may play a role in cytomegalovirus (CMV) infection. Since annexin II has been shown to mediate aggregation and fusion of certain membranes, we investigated whether these properties could be exploited by CMV directly. The experiments showed that purified annexin II, but not the homologous protein annexin V (AnV), can mediate the binding of 35S-CMV (strain AD169) to anPL-coated microtiter wells. This association required Ca2+, could be titrated by varying either annexin II (apparent Kd = 4 x 10(-)8 M) or 35S-CMV, was inhibited by unlabeled CMV, and was observed for the heterotetrameric or monomeric form of annexin II. In experiments utilizing the fluorescence dequenching of octadecyl rhodamine incorporated into the CMV envelope, annexin II was furthermore found to enhance the rate of virus-anPL vesicle fusion. The observed fusion was dependent on the concentration of annexin II, Ca2+, and anPL and was mediated principally by the heterotetramer. Interestingly, AnV was observed to inhibit the effects of annexin II on CMV fusion but not binding to anPL, which indicates that annexin II enhances these processes by distinct mechanisms. The results presented here provide the first direct evidence that annexin II has the capacity to bridge CMV to a phospholipid membrane and to enhance virus-membrane fusion. These observations furthermore suggest that AnV may regulate the fusogenic function of annexin II.
authors.affiliation: Canadian Blood Services, R&D Department, University of Ottawa, Ontario, Canada.
authors.forename: C M
authors.initials: CM
authors.lastname: Raynor
authors.forename: J F
authors.initials: JF
authors.lastname: Wright
authors.forename: D M
authors.initials: DM
authors.lastname: Waisman
authors.forename: E L
authors.initials: EL
authors.lastname: Pryzdial
mesh_terms: D000838:Anions; D017306:Annexin A2 / Q000378:metabolism / Q000502:physiology*; D001665:Binding Sites; D001667:Binding, Competitive; D003587:Cytomegalovirus / Q000378:metabolism / Q000502:physiology*; D006801:Humans; D008051:Lipid Bilayers / Q000378:metabolism; D008561:Membrane Fusion / Q000187:drug effects; D010743:Phospholipids / Q000378:metabolism*; D013462:Sulfur Radioisotopes; D014764:Viral Proteins / Q000378:metabolism / Q000502:physiology*
chemical_list: D000838:Anions; D017306:Annexin A2; D008051:Lipid Bilayers; D010743:Phospholipids; D013462:Sulfur Radioisotopes; D014764:Viral Proteins